Ditchcarbon
  • Contact
  1. Organizations
  2. AbbVie Products LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

AbbVie Products LLC Sustainability Profile

Company website

AbbVie Products LLC, a leading biopharmaceutical company headquartered in the United States, has established itself as a key player in the global healthcare industry since its founding in 2013. With a strong focus on immunology, oncology, neuroscience, and virology, AbbVie is renowned for its innovative therapies that address complex health challenges. The company’s flagship products, including Humira and Imbruvica, are distinguished by their unique mechanisms of action and proven efficacy, making significant impacts on patient care. AbbVie has achieved notable milestones, including strategic acquisitions and a robust pipeline of new treatments, solidifying its market position as a trusted provider of advanced medical solutions. With operations spanning North America, Europe, and beyond, AbbVie continues to drive advancements in healthcare, committed to improving patient outcomes worldwide.

DitchCarbon Score

How does AbbVie Products LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

65

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

AbbVie Products LLC's score of 65 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

78%

Let us know if this data was useful to you

AbbVie Products LLC's reported carbon emissions

Inherited from AbbVie Inc.

AbbVie Products LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of AbbVie Inc., any emissions data or climate commitments would be inherited from its parent company. AbbVie Inc. has made significant strides in addressing climate change, with initiatives cascaded down to AbbVie Products LLC. However, specific reduction targets or achievements for AbbVie Products LLC are not detailed. The company is aligned with industry standards and participates in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from AbbVie Inc. at a cascade level of 1. While no absolute emissions numbers are provided, AbbVie Inc. is committed to reducing its carbon footprint and enhancing sustainability practices across its operations. The absence of specific data does not diminish the company's commitment to climate action and its role within the broader corporate family focused on environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
402,448,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
-
-
-
-

How Carbon Intensive is AbbVie Products LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. AbbVie Products LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is AbbVie Products LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for AbbVie Products LLC is in US, which has a low grid carbon intensity relative to other regions.

AbbVie Products LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

AbbVie Products LLC has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare AbbVie Products LLC's Emissions with Industry Peers

Ferring Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251210.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy